Impact of a Hypnotic Recording on Artifacts in 4D CT in the Context of Stereotactic Body Radiation Therapy for Lung Cancer

NCT ID: NCT07334990

Last Updated: 2026-01-12

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 25 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-12-30
• Study Completion Date: 2027-01-30

Brief Summary

This is a single-center prospective cohort study evaluating the impact of a simple audio recording hypnosis system on the occurrence of artifacts on 4D CT scans in patients requiring SBRT radiotherapy for lung lesions (peripheral or central).

The primary objective of the study is to evaluate the use of a hypnotic recording on the reduction of artifacts in 4D CT scans for patients undergoing stereotactic body radiation therapy for lung cancer.

The secondary objectives are to evaluate:

• the impact of hypnotic recording on the reduction of artifacts on intrathoracic structures (trachea, main bronchi, diaphragm, lesions, heart, and lungs),
• the regularity of respiratory amplitude,
• the regularity of respiratory rate,
• the volume of Internal Target Volume (ITV),
• the reproducibility of ITV volume,
• patient satisfaction.

1. Before this dosimetric scan, the patient will complete a self-administered questionnaire on anxiety: the HADS-A questionnaire (Hospital Anxiety and Depression Scale-only questions relating to anxiety).

During this examination, the MERM explains the dosimetric scan procedure to the patient. After the immobilization system has been set up in accordance with the department's standard protocol, a 4D CT scan will be performed while asking the patient to breathe regularly. In the event of an artifact at the level of the lesion, a second 4D CT scan will be performed under the same conditions.

2. The hypnotic audio recording will be played through the room's speakers. The hypnotic recording is structured in three stages, with a 5-minute induction phase, a 5-minute working phase, and finally a 5-minute return phase.

After 5 minutes of playback, the 4D CT scan for the study is performed using the same acquisition parameters as the free 4D CT scan.

3. Following the first radiotherapy session and for all patients included in the study, a 4D dosimetric scan will be performed using the hypnotic recording again, as described above, in order to assess the inter-fraction reproducibility of the ITV volume.

Following this second 4D CT scan under hypnosis, patient satisfaction will be assessed (using a Likert scale questionnaire).

Conditions

Stereotactic Body Radiation Therapy; Lung Lesions

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Hypnotic record

Group Type: EXPERIMENTAL

Hypnotic record

Intervention Type: OTHER

The hypnotic audio recording will be played through the room's speakers. The hypnotic recording is structured in three stages, with a 5-minute induction phase, a 5-minute working phase, and finally a 5-minute return phase.

Interventions

Hypnotic record

The hypnotic audio recording will be played through the room's speakers. The hypnotic recording is structured in three stages, with a 5-minute induction phase, a 5-minute working phase, and finally a 5-minute return phase.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Age ≥18 years,
• Indication for lung SBRT, peripheral or central lesion,
• Patient new to hypnosis (medical or stage hypnosis),
• Patient covered by social security or equivalent,
• Dated and signed consent form.

Exclusion Criteria

• Indication for treatment with abdominal compression,
• Patient undergoing treatment for multiple lesions in the same treatment sequence,
• Patient with an ultra-central lesion (distance to the mediastinum < 2 cm),
• Patient already included in this protocol,
• Cognitive or physical disorders preventing the trial from proceeding smoothly,
• Patient with one or more active psychotic disorders (such as schizophrenia),
• Patients suffering from severe dissociative disorders,
• Patient who does not understand French or is deaf,
• Pregnant or breastfeeding women,
• Patient under guardianship or curatorship or deprived of liberty.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Centre Leon Berard

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Central Contacts

Céline KERMORGANT

Role: CONTACT

celine.kermorgant@lyon.unicancer.fr

+33 4 78 78 28 28

Séverine METZGER

Role: CONTACT

+33478782786

Other Identifiers

ET25-084

Identifier Type: -

Identifier Source: org_study_id